These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15871769)

  • 1. (Mis)Interpretations of leukoplakia.
    Auluck A; Pai KM
    J Can Dent Assoc; 2005 Apr; 71(4):237-8. PubMed ID: 15871769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral leukoplakia. Current concepts and analysis of the term in the Spanish language].
    Moreira Díaz EE; Baláez AB
    Rev Cubana Estomatol; 1989; 26(3):138-47. PubMed ID: 2640056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomenclature and classification of potentially malignant disorders of the oral mucosa.
    Warnakulasuriya S; Johnson NW; van der Waal I
    J Oral Pathol Med; 2007 Nov; 36(10):575-80. PubMed ID: 17944749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge about oral leukoplakia for use at different levels of expertise, including patients.
    van der Waal I
    Oral Dis; 2018 Mar; 24(1-2):174-178. PubMed ID: 29480645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The definition and rating system of oral leukoplakia (interim provisions)].
    Society of Oral Medicine, Chinese Stomatological Association
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Oct; 46(10):579-80. PubMed ID: 22321624
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical-therapeutic approach in oral leukoplasia].
    Camacho Alonso F; López Jornet P
    Rev Clin Esp; 2004 Aug; 204(8):420-1. PubMed ID: 15274767
    [No Abstract]   [Full Text] [Related]  

  • 7. Metallothionein immunoexpression in oral leukoplakia.
    Johann AC; da Silveira-Júnior JB; Souto GR; Horta MC; Aguiar MC; Mesquita RA
    Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E156-60. PubMed ID: 18305434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with oral cancer developing from pre-existing oral leukoplakia: do they do better than those with de novo oral cancer?
    Weijers M; Ten Hove I; Allard RH; Bezemer DP; van der Waal I
    J Oral Pathol Med; 2008 Mar; 37(3):134-6. PubMed ID: 18251936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTT1 polymorphism and oral leukoplakia.
    Barroso Duarte EC; Da Silva MS; Gomez MV; Gomez RS
    Anticancer Res; 2006; 26(1A):427-30. PubMed ID: 16475728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence rates for oral leukoplakia and lichen planus in a Japanese population.
    Nagao T; Ikeda N; Fukano H; Hashimoto S; Shimozato K; Warnakulasuriya S
    J Oral Pathol Med; 2005 Oct; 34(9):532-9. PubMed ID: 16138891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of oral candida to development of oral leukoplakia into cancer].
    Cao J; Liu HW; Jin JQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():90-3. PubMed ID: 17767868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology.
    Odani T; Ito D; Li MH; Kawamata A; Isobe T; Iwase M; Nagumo M
    Int J Oncol; 2006 Mar; 28(3):619-24. PubMed ID: 16465365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A SURVEY OF THE USE OF THE TERM "LEUKOPLAKIA" BY ORAL PATHOLOGISTS.
    SPRAGUE WG
    Oral Surg Oral Med Oral Pathol; 1963 Sep; 16():1067-74. PubMed ID: 14061142
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma.
    Kondoh N; Ohkura S; Arai M; Hada A; Ishikawa T; Yamazaki Y; Shindoh M; Takahashi M; Kitagawa Y; Matsubara O; Yamamoto M
    Oral Oncol; 2007 May; 43(5):455-62. PubMed ID: 16979924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSTM1 polymorphism and oral leukoplakia.
    Duarte EC; da Silva MS; Gomez MV; Gomez RS
    J Oral Pathol Med; 2006 Apr; 35(4):202-5. PubMed ID: 16519766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA cytometry of oral leukoplakia and oral lichen planus.
    Martin P
    Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E221; author reply E221-2. PubMed ID: 16505806
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280).
    Majumder M; Sikdar N; Paul RR; Roy B
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2106-12. PubMed ID: 16172217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "DNA ploidy in proliferative verrucous leukoplakia".
    Olofsson J
    Oral Oncol; 2007 Jul; 43(6):621; discussion 622-3. PubMed ID: 17526426
    [No Abstract]   [Full Text] [Related]  

  • 20. [The relevance of oral leukoplakia and oral lichen planus to gene single nucleotide polymorphism].
    Wei BJ; Zhou ZT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Dec; 41(12):770-1. PubMed ID: 17349206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.